Johnson & Johnson

Pharmalot By Ed Silverman

J&J changes policy on use of animals after PETA protest

Pharmalot By Ed Silverman

Are concerns about a price war between Johnson & Johnson and Pfizer ‘overblown’?

Health By Helen Branswell

J&J to start testing vaccine for Ebola strains, Marburg virus

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: India plans tougher penalties for bribing doctors

Pharmalot By Ed Silverman

Long Island county sues opioid drug makers for misleading marketing

Pharmalot By Ed Silverman

Yet another state sues J&J for allegedly hiding vaginal mesh risks

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Express Scripts criticized for not disclosing info about key committee

Pharmalot By Ed Silverman

Some biosimilars are just as good as some pricey biologics

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Did Abbott rep in India kill himself over sales goals?

Pharmalot By Ed Silverman

A Johnson & Johnson unit to pay $18 million for causing false claims

Pharmalot By Ed Silverman

Former execs at J&J division convicted of illegally distributing devices

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pharma faces challenges as AIDS patients live longer

Pharmalot By Ed Silverman

J&J must pay $70 million to male teen who took Risperdal and developed large breasts

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

J&J sued by two states, alleging hidden vaginal mesh risks

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Investors tell pharma to ‘take control’ of the pricing debate

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: J&J ordered to pay $55m in talcum powder trial

Pharmalot By Ed Silverman

More drug makers are taking hefty price hikes on more drugs

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pfizer and Allergan call off their merger

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Drug makers threaten to cut R&D spending in Japan

Pharmalot By Ed Silverman

Drug makers paid fewer fines for bad behavior in recent years

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Johnson & Johnson to pay $498M over hip implant injuries

Pharmalot By Ed Silverman

Most Read

Virtual care companies rush to ease access to Covid-19 antivirals

Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron

Hospitals and doctors fail to stop end-of-year Medicare cuts, for now

Second U.S. case of Omicron variant indicates domestic transmission

Most advanced lab-grown human embryos prompt a pressing question: Are they getting too real?

Docs pitch the C-suite on tech & why telehealth pricing matters

Pharmalittle: Glaxo and Vir drug appears to work against Omicron; employees sue Bristol Myers over vaccine mandate

Biden’s new Covid plan: more boosters, free home testing, and ‘monoclonal antibody strike teams’

All Coverage

J&J changes policy on use of animals after PETA protest

Are concerns about a price war between Johnson & Johnson and Pfizer ‘overblown’?

J&J to start testing vaccine for Ebola strains, Marburg virus

Pharmalot, Pharmalittle: India plans tougher penalties for bribing doctors

Long Island county sues opioid drug makers for misleading marketing

Yet another state sues J&J for allegedly hiding vaginal mesh risks

Pharmalot, Pharmalittle: Express Scripts criticized for not disclosing info about key committee

Some biosimilars are just as good as some pricey biologics

Pharmalot, Pharmalittle: Did Abbott rep in India kill himself over sales goals?

A Johnson & Johnson unit to pay $18 million for causing false claims

Former execs at J&J division convicted of illegally distributing devices

Pharmalot, Pharmalittle: Pharma faces challenges as AIDS patients live longer

J&J must pay $70 million to male teen who took Risperdal and developed large breasts

Up and down the ladder: The latest comings and goings

Up and down the ladder: The latest comings and goings

J&J sued by two states, alleging hidden vaginal mesh risks

Pharmalot, Pharmalittle: Investors tell pharma to ‘take control’ of the pricing debate

Pharmalot, Pharmalittle: J&J ordered to pay $55m in talcum powder trial

More drug makers are taking hefty price hikes on more drugs

Pharmalot, Pharmalittle: Pfizer and Allergan call off their merger

Up and down the ladder: The latest comings and goings

Pharmalot, Pharmalittle: Drug makers threaten to cut R&D spending in Japan

Drug makers paid fewer fines for bad behavior in recent years

Pharmalot, Pharmalittle: Johnson & Johnson to pay $498M over hip implant injuries

Up and down the ladder: The latest comings and goings